(Q48624959)

13 February 2018

title

Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group. (English)

1 reference

13 February 2018

amoxicillin/clavulanic acid

main subject

1 reference

File T

1

1 reference

13 February 2018

Schlemmer B

2

1 reference

13 February 2018

Garau J

3

1 reference

13 February 2018

Lode H

4

1 reference

13 February 2018

Lynch S

5

1 reference

13 February 2018

Young C

6

1 reference

13 February 2018

publication date

1 August 2000

1 reference

13 February 2018

published in

Journal of Chemotherapy

1 reference

13 February 2018

volume

12

1 reference

13 February 2018

page(s)

314-325

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2000.12.4.314

The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2000.12.4.314

Amoxycillin clavulanate: an assessment after 15 years of clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2000.12.4.314

Determinants of non-compliance with short term antibiotic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2000.12.4.314

10.1179/JOC.2000.12.4.314

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

10949981

1 reference

13 February 2018